Article
How I diagnose and treat atypical hemolytic uremic syndrome
2 Nov 2022
Abstract excerpt
Our understanding and management of atypical hemolytic uremic syndrome (aHUS) have dramatically improved in the last decade. aHUS has been established as a prototypic disease resulting from a dysregulation of the complement alternative C3 convertase. Subsequently, prospective nonrandomized studies and retrospective series have shown the efficacy of C5 blockade in the treatment of this devastating disease. C5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
